ICF

ICF has been founded in 2002 and it has been the first Brazilian bioequivalence and bioavailability laboratory to get certified by ANVISA (Brazil). It is one of the largest pharmaceutical research centers in Brazil and in Latin America and a notable reference for industries and investors from several countries. ICF's commitment with ethics and innovation assure the credibility and quality of our products. ICF has already conducted over 700 bioequivalence studies and it takes part in the history of generic drugs in Brazil. We offer one of the biggest hospital infrastructures in the country with a high technology, diversified portfolio and certificate, two hundred bioanalytical methods – including high complexity methods such as hormones and sprays.